Transmission Dynamics of Carbapenemase Genes in CREC, China
2026-05-01
Characterizing Carbapenemase Gene Transmission in CREC: Insights from Eight Hospitals in Guangdong
Study Background and Research Question
Carbapenem-resistant Enterobacter cloacae (CREC) has become a critical concern in global public health, particularly as part of the larger challenge posed by carbapenem-resistant Enterobacteriaceae (CRE) (paper). In China, CREC now ranks third among CRE isolates, following Klebsiella pneumoniae and Escherichia coli. The COVID-19 pandemic has exacerbated antimicrobial resistance (AMR) risks due to increased antibiotic usage, disruptions in standard infection control, and complex patient management. However, there remains a knowledge gap regarding the distribution and transmission dynamics of carbapenemase-encoding genes (CEGs) within CREC, especially under pandemic conditions. The present study addresses this by systematically characterizing 54 CREC strains collected from eight teaching hospitals in Guangdong, China, between December 2022 and June 2024, focusing on the genetic and epidemiologic contexts of resistance determinants (paper).Key Innovation from the Reference Study
The study’s principal innovation lies in its integrative analysis of CEGs within a defined temporal and geographic hospital network during a period of heightened AMR risk. By employing a combination of molecular typing, plasmid profiling, and conjugation assays, the authors provide a granular view of how resistance genes—especially blaNDM-1—are distributed between plasmids and chromosomes and how readily they can be horizontally transferred. The research also uniquely contextualizes transmission dynamics with epidemiologic data (age, gender, clinical department, specimen type), offering actionable insights for both surveillance and intervention (paper).Methods and Experimental Design Insights
The study employed a rigorous methodology that combined classical microbiological techniques with molecular biology protocols:- Bacterial Collection: 54 non-duplicate CREC isolates were collected from eight teaching hospitals over an 18-month period.
- Genetic Characterization: The presence of carbapenemase genes (blaNDM-1, blaIMP, blaKPC-2) was determined using PCR and further mapped to chromosomal or plasmid locations via variable temperature SDS plasmid elimination.
- Antimicrobial Susceptibility: Broth microdilution assays were used to assess resistance profiles for multiple drug classes, including beta-lactams, aminoglycosides, and fluoroquinolones.
- Conjugation Assays: Plasmid-mediated transferability of CEGs was evaluated, and success rates for gene transfer were calculated.
- Mobile Genetic Elements: The study identified six types of mobile genetic elements associated with CEGs, with ISEcp1 being the most prevalent.
- Genotyping: ERIC-PCR and NTSYS software were used for clonal analysis, revealing 17 genotypes among the isolates.
Protocol Parameters
- assay | variable temperature SDS plasmid elimination | 42-45°C, SDS 0.02% | mapping plasmid vs. chromosomal location of resistance genes | ensures accurate genetic context assignment | paper
- assay | PCR for CEG detection | standard thermocycling, published primers | confirmation of blaNDM-1, blaIMP, blaKPC-2 presence | gold standard for gene presence | paper
- assay | broth microdilution | CLSI-recommended concentrations | quantification of MIC for imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, levofloxacin | standardized resistance measurement | paper
- assay | conjugation experiment | 18-24h incubation, recipient E. coli J53 | assessing horizontal gene transfer potential | tracks real-world dissemination risk | paper
- assay | ERIC-PCR for genotyping | DNA fingerprinting, NTSYS clustering | delineates clonal spread and outbreak potential | supports epidemiologic mapping | paper
Core Findings and Why They Matter
The study’s findings offer several critical insights for AMR research and infection control strategies:- High Prevalence of CEGs: 85.19% of CREC isolates harbored at least one carbapenemase-encoding gene (paper).
- Dominance of blaNDM-1: This gene was found either on both chromosomes and plasmids (33.33%) or exclusively on plasmids (46.30%)—highlighting its central role in resistance dissemination (paper).
- Horizontal Transfer Efficiency: Conjugation experiments showed a 95.65% success rate in transferring CEGs, underscoring the high risk of rapid resistance spread (paper).
- Mobile Genetic Elements: ISEcp1 was the most frequently detected element (87.04%), supporting the hypothesis that integrative and conjugative elements play a significant role in gene mobilization (paper).
- Multidrug Resistance: CEG-positive isolates exhibited significantly greater resistance to beta-lactams and other classes, including imipenem, cefepime, gentamicin, and quinolones (paper).
- Clonal Diversity: Genotyping revealed 17 distinct CREC types, with certain clones (types E and G) disseminated across multiple hospital departments, suggesting both horizontal and vertical transmission routes.
- Epidemiological Patterns: Higher rates of CEG detection were observed in male and elderly patients, respiratory medicine departments, and sputum samples, providing direction for targeted surveillance (paper).
Comparison with Existing Internal Articles
Internal resources, such as "Cefotaxime in Molecular Epidemiology" and "Cefotaxime: A Benchmark Third-Generation Cephalosporin", emphasize the utility of third-generation cephalosporin antibiotics in dissecting resistance mechanisms in both Gram-positive and Gram-negative bacteria. These articles highlight the role of cefotaxime as a stable, beta-lactamase-resistant agent for probing antimicrobial resistance and transmission in bacterial infection models. The present study complements these resources by detailing the mechanisms and epidemiology of carbapenemase gene transfer, especially in clinical settings where resistance genes, such as blaNDM-1, are highly mobile and multidrug resistance is prevalent (internal; internal). The reference paper’s focus on Enterobacter cloacae and carbapenemase dynamics extends the molecular epidemiology themes found in these internal articles by providing direct evidence of real-world resistance gene transfer, further underpinning the importance of surveillance and mechanism-focused research. For detailed practical workflows involving third-generation cephalosporins in molecular AMR research, readers can consult "Cefotaxime in Antimicrobial Resistance Research: Protocols & Insights".Limitations and Transferability
While the study offers rich molecular and epidemiological data, several limitations merit attention:- Geographic Scope: All isolates were collected from hospitals in Guangdong, which may limit generalizability to other regions or healthcare systems (paper).
- Temporal Window: The study period (2022–2024) coincides with the COVID-19 pandemic, possibly influencing resistance patterns due to unique pressures not present in non-pandemic periods.
- Genetic Diversity: Although genotyping was thorough, whole-genome sequencing could provide even finer resolution of resistance determinants and mobile elements.
- Clinical Outcomes: The study does not directly link molecular findings to patient outcomes or treatment efficacy.